Phil Secures $25MM in Series B Funding

philPhil, Inc., a San Francisco, CA-based technology platform for distributing and managing specialty prescription drugs, closed a $25M Series B funding round.

The round was led by new investor GreatPoint Ventures, with participation from Tarsadia Investments, Crosslink Capital and Uncork Capital.

The company intends to use the funds to accelerate growth, with a focus on hiring technical talent and expanding geographic presence.

Led by founder & CEO Deepak Thomas, Phil provides a prescription management software platform that connects patients, prescribers, pharmacies and manufacturers with the goal of lowering systemic cost and improving outcomes for patients.
The platform currently connects over 36,000 prescribers in all major states with their patients and independent pharmacies across the nation.



Join the discussion